ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1,2,Deafness,Hearing losses,Hearing disorders,Ear,N
1,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
2,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6,2,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
6,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
7,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
7,3,Glabellar reflex abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
7,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
7,5,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
7,6,Reduced facial expression,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
8,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
11,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
12,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
12,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
13,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
13,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,1,Deafness,Hearing losses,Hearing disorders,Ear,N
15,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
15,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
16,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
16,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,1,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
17,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
17,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
18,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
19,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
20,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
20,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
20,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
20,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
20,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
20,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
20,8,Myopathy,Myopathies,Muscle disorders,Musc,N
20,9,Necrotising myositis,Myopathies,Muscle disorders,Musc,N
20,10,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
21,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
21,2,Large intestine infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
21,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
22,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
23,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
24,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
24,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
25,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
26,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
27,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
29,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
29,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
31,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
32,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
33,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
33,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
34,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
35,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
36,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
36,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
38,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
39,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
40,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
41,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
42,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
42,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
43,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
44,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
45,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
45,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
46,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
46,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
46,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
46,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
48,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
48,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
48,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
48,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
49,2,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
49,3,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
49,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
49,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
50,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
50,2,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
50,3,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
50,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
50,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
51,1,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
52,1,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
53,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
54,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
56,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
56,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
56,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
57,2,Genital swelling,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
57,3,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
57,4,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
58,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
60,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
60,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
60,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
60,5,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
60,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
60,7,Headache,Headaches NEC,Headaches,Nerv,N
60,8,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
60,9,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
60,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
60,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
60,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
60,13,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
60,14,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,15,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
61,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
61,3,Muscle necrosis,Myopathies,Muscle disorders,Musc,N
61,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
61,5,Myopathy,Myopathies,Muscle disorders,Musc,N
61,6,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
61,7,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
62,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
62,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,3,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
62,4,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
62,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
62,6,Myopathy,Myopathies,Muscle disorders,Musc,N
62,7,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
63,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
63,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,3,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
63,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
64,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
64,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
65,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
65,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
66,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
66,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
66,4,Headache,Headaches NEC,Headaches,Nerv,N
66,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
67,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
67,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
68,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
69,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
70,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
70,2,Aerophagia,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
70,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
70,6,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
70,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,9,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
70,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
71,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
71,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
71,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
71,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
71,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
71,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
71,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
71,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
71,10,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
71,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
72,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
72,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
72,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
72,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
72,6,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
72,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
72,8,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
72,9,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
72,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
72,11,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
72,12,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
73,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
73,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
75,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
75,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
75,3,Headache,Headaches NEC,Headaches,Nerv,N
75,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
76,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
76,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
78,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
78,2,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
78,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
79,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
79,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
79,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
79,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
79,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
79,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
79,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
79,10,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
79,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
80,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
